Does CLINDAMYCIN Cause Malignant neoplasm progression? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Malignant neoplasm progression have been filed in association with CLINDAMYCIN (XACIATO). This represents 0.1% of all adverse event reports for CLINDAMYCIN.
13
Reports of Malignant neoplasm progression with CLINDAMYCIN
0.1%
of all CLINDAMYCIN reports
2
Deaths
11
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CLINDAMYCIN?
Of the 13 reports, 2 (15.4%) resulted in death, 11 (84.6%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLINDAMYCIN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does CLINDAMYCIN Cause?
Drug hypersensitivity (3,900)
Drug ineffective (1,894)
Rash (1,325)
Diarrhoea (1,206)
Off label use (901)
Nausea (803)
Pruritus (776)
Dyspnoea (607)
Condition aggravated (605)
Pyrexia (605)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CLINDAMYCIN Alternatives Have Lower Malignant neoplasm progression Risk?
CLINDAMYCIN vs CLINDAMYCIN\CLINDAMYCIN
CLINDAMYCIN vs CLINDAMYCIN\TRETINOIN
CLINDAMYCIN vs CLIOQUINOL
CLINDAMYCIN vs CLIOQUINOL\FLUMETHASONE
CLINDAMYCIN vs CLOBAZAM